Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1858113 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL9870336 | 0.98 | CYP1A2 (0.96) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL11544283 | 0.98 | CYP1A2 (0.96) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL1127792 | 0.98 | CYP1A2 (0.96) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT | |
| SCHEMBL857572 | 0.98 | SMN1; SMN2 (0.95) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT | |
| Methane SCHEMBL11633126 | 0.96 | CYP1A2 (0.92) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT | |
| Bromide SCHEMBL11793837 | 0.95 | SMN1; SMN2 (0.91) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL946654 | 0.95 | SMN1; SMN2 (0.91) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT | |
| SCHEMBL2639576 | 0.93 | CYP1A2 (0.88) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT | |
| SCHEMBL547192 | 0.93 | CYP1A2 (0.88) | SMN1; SMN2CYP1A2MAPK1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117384969-A | Transfection reagent and preparation method and application thereof | 上海市第六人民医院 | 2024-01-12 | — | — | CN | claimed |
| EP-2968145-A1 | MODIFIED DOCETAXEL LIPOSOME FORMULATIONS | Mallinckrodt LLC (US) | 2016-01-20 | — | — | EP | claimed |
| CN-105188675-A | Modified docetaxel liposome formulations | MALLINCKRODT LLC | 2015-12-23 | — | — | CN | claimed |
| WO-2014160392-A1 | MODIFIED DOCETAXEL LIPOSOME FORMULATIONS | MALLINCKRODT LLC (US) | 2014-10-02 | — | — | WO | claimed |
| US-8598359-B2 | Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation | DECODE GENETICS EHF (IS) | 2013-12-03 | — | — | US | claimed |
| US-20100113450-A1 | Agent for Preventing and Alleviating Wrinkles | SHISEIDO COMPANY LTD. (JP) | 2010-05-06 | — | — | US | claimed |
| EP-2136859-A2 | NITRIC OXIDE DONATING MEDICAL DEVICES AND METHODS OF MAKING SAME | Medtronic Vascular Inc. (US) | 2009-12-30 | — | — | EP | claimed |
| EP-2123253-A1 | WRINKLING-PREVENTING AND -MODIFYING AGENT | Shiseido Company, Ltd. (JP) | 2009-11-25 | — | — | EP | claimed |
| WO-2008112391-A2 | NITRIC OXIDE DONATING MEDICAL DEVICES AND METHODS OF MAKING SAME | MEDTRONIC VASCULAR INC. (US) | 2008-09-18 | — | — | WO | claimed |
| US-20080220040-A1 | Nitric Oxide Donating Medical Devices and Methods of Making Same | MEDTRONIC VASCULAR, INC. (US) | 2008-09-11 | — | — | US | claimed |
| EP-0882712-B1 | PROCESS FOR PREPARING ACID SALTS OF GAMMA-(PIPERIDYL)BUTYRIC ACID | KOEI CHEMICAL CO (JP) | 2003-04-23 | — | — | EP | claimed |
| US-6197961-B1 | HYDROGENATION OF G-(PYRIDYL)BUTYRIC ACID SALT IN SOLVENT USING PALLADIUM, RHODIUM, OR RUTHENIUM CATALYST; HYDROLYSIS, DECARBOXYLATION | KOEI CHEMICAL CO., LTD. (JP) | 2001-03-06 | — | — | US | claimed |
| EP-0882712-A1 | PROCESS FOR PREPARING ACID SALTS OF $g(g)-(PIPERIDYL)BUTYRIC ACID | KOEI CHEMICAL CO., LTD. (JP) | 1998-12-09 | — | — | EP | claimed |
| US-12551418-B2 | Cosmetic containing ultraviolet wavelength converting substance and medicinal agent | SHISEIDO COMPANY, LTD. (JP) | 2026-02-17 | — | — | US | disclosed |
| US-20250154140-A1 | ISOQUINOLINE DERIVATIVES AS INHIBITORS OF BAX AND/OR BAK, COMPOSITIONS AND USES THEREOF | Sunnybrook Research Institute (CA) | 2025-05-15 | — | — | US | disclosed |
| US-20250082559-A1 | EXTERNAL-USE SKIN PREPARATION COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2025-03-13 | — | — | US | disclosed |
| US-4025630-A | Anesthesia methods using benzopyrans and esters thereof as pre-anesthesia medication | ABBOTT LABORATORIES (US) | 1977-05-24 | — | — | US | disclosed |
| US-4020163-A | Use of heterocyclic esters of 5H-[1]benzopyrano [3,4-b]pyridines as analgesics | SHARPS ASSOCIATES (US) | 1977-04-26 | — | — | US | disclosed |
| US-3991194-A | Heterocyclic esters of benzopyranopyridines | SHARPS ASSOCIATES (US) | 1976-11-09 | — | — | US | disclosed |
| US-3941782-A | Heterocyclic esters of benzopyrans | SHARPS ASSOCIATES (US) | 1976-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250082559-A1 | EXTERNAL-USE SKIN PREPARATION COMPOSITION | TYR, CUTA, NACA | SMN1; SMN2 4414/4885CYP1A2 302/4885MAPK1 2544/4885 |
| US-20100113450-A1 | Agent for Preventing and Alleviating Wrinkles | GABRB1, GABRB2, GABBR1 | SMN1; SMN2 1147/4885CYP1A2 706/4885MAPK1 2400/4885 |
| US-20250154140-A1 | ISOQUINOLINE DERIVATIVES AS INHIBITORS OF BAX AND/OR BAK, COMPOSITIONS AND USES THEREOF | BAK1, BAX, BCL2 | SMN1; SMN2 424/4885CYP1A2 2086/4885MAPK1 1062/4885 |
| US-12551418-B2 | Cosmetic containing ultraviolet wavelength converting substance and medicinal agent | GLA, PGA5, AGER | SMN1; SMN2 3929/4885CYP1A2 2324/4885MAPK1 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.